Proteocyte AI featured in online publication 360Dx

Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, was recently featured in 360Dx.  360Dx covers emerging economic and technological trends in the clinical diagnostic...

read more

Today Proteocyte Diagnostics becomes…

  Proteocyte Diagnostics, a computational pathology company that has built a platform-based technology that predicts your risk of developing cancer, announced a name change to Proteocyte AI, effectively immediately. “Our new corporate identity better reflects how...

read more

Proteocyte Diagnostics closes $605,000 in funding

Proteocyte Diagnostics Inc. of Toronto today announced funding closed in the amount of $605,000 CDN including investments from Ontario Centres of Excellence (OCE) and a private syndicate of investors. “We are delighted with the support and investment by OCE and our...

read more
Sign up for our mailing list!